JP2023510971A5 - - Google Patents

Info

Publication number
JP2023510971A5
JP2023510971A5 JP2022544123A JP2022544123A JP2023510971A5 JP 2023510971 A5 JP2023510971 A5 JP 2023510971A5 JP 2022544123 A JP2022544123 A JP 2022544123A JP 2022544123 A JP2022544123 A JP 2022544123A JP 2023510971 A5 JP2023510971 A5 JP 2023510971A5
Authority
JP
Japan
Prior art keywords
carbonyl
carboxamide
methylimidazole
chloro
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022544123A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510971A (ja
JP7715715B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/051095 external-priority patent/WO2021148420A1/en
Publication of JP2023510971A publication Critical patent/JP2023510971A/ja
Publication of JP2023510971A5 publication Critical patent/JP2023510971A5/ja
Application granted granted Critical
Publication of JP7715715B2 publication Critical patent/JP7715715B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022544123A 2020-01-22 2021-01-20 新規複素環式化合物 Active JP7715715B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2020073830 2020-01-22
CNPCT/CN2020/073830 2020-01-22
PCT/EP2021/051095 WO2021148420A1 (en) 2020-01-22 2021-01-20 Novel heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2023510971A JP2023510971A (ja) 2023-03-15
JP2023510971A5 true JP2023510971A5 (https=) 2024-01-22
JP7715715B2 JP7715715B2 (ja) 2025-07-30

Family

ID=74418400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544123A Active JP7715715B2 (ja) 2020-01-22 2021-01-20 新規複素環式化合物

Country Status (5)

Country Link
US (1) US20220396565A1 (https=)
EP (1) EP4093734A1 (https=)
JP (1) JP7715715B2 (https=)
CN (1) CN114981259B (https=)
WO (1) WO2021148420A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4211116B1 (en) * 2020-09-07 2024-08-07 F. Hoffmann-La Roche AG Novel heterocyclic antibiotics
JP2024506021A (ja) * 2021-02-07 2024-02-08 エフ. ホフマン-ラ ロシュ アーゲー 新規ヘテロアリール置換イミダゾール誘導体
CN117715892A (zh) * 2021-07-06 2024-03-15 豪夫迈·罗氏有限公司 用于治疗细菌感染的季铵阳离子取代化合物
JP2024525793A (ja) * 2021-07-15 2024-07-12 エフ. ホフマン-ラ ロシュ アーゲー イミダゾール誘導体及びその抗生物質としての使用
JP2025508473A (ja) * 2022-02-25 2025-03-26 エフ. ホフマン-ラ ロシュ アーゲー 両性イオン性抗菌化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849660B1 (en) * 2000-08-01 2005-02-01 Isis Pharmaceuticals, Inc. Antimicrobial biaryl compounds
GB201406956D0 (en) * 2014-04-17 2014-06-04 Univ Nottingham Compounds
AU2016347456B2 (en) 2015-10-27 2018-12-13 F. Hoffmann-La Roche Ag Peptide macrocycles against acinetobacter baumannii
CA3068305A1 (en) * 2017-06-29 2019-01-03 Rigel Pharmaceuticals, Inc. Kinase inhibitors and methods for making and using
US10471045B2 (en) * 2017-07-21 2019-11-12 The University Of Hong Kong Compounds and methods for the treatment of microbial infections
US11505573B2 (en) 2018-03-28 2022-11-22 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
US11819532B2 (en) 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii
CN113164771A (zh) * 2018-12-17 2021-07-23 豪夫迈·罗氏有限公司 咪唑并吡嗪衍生物作为抗菌剂
WO2020182648A1 (en) * 2019-03-08 2020-09-17 F. Hoffmann-La Roche Ag Novel imidazole-pyrazole derivatives

Similar Documents

Publication Publication Date Title
JP2023510971A5 (https=)
JP2022548690A5 (https=)
JP2025016684A5 (https=)
CN103282360B (zh) Cxcr4受体拮抗剂
RU2451674C2 (ru) Пиридинкарбоксамиды в качестве ингибиторов 11-бета-hsd1
JP6479029B2 (ja) ムスカリンm1受容体アゴニストとしての二環式アザ化合物
JP2010508338A5 (https=)
RU2378259C2 (ru) Новые производные аминоиндазолов в качестве лекарственных средств и содержащие их фармацевтические композиции
JP4854511B2 (ja) 糖尿病治療剤
JP7217273B6 (ja) ピリジンカルボニル誘導体およびtrpc6阻害剤としてのその治療的使用
CN103052636B (zh) D2拮抗剂及其合成方法和使用方法
RU2013157374A (ru) Производное индазола и пирролопиридина и его фармацевтическое применение
JP2021535134A5 (https=)
JP7715715B2 (ja) 新規複素環式化合物
RU2010106974A (ru) Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3
US8658639B2 (en) N-substituted-cyclic amino derivative
JP2020502058A (ja) ジアシルグリセリドo−アシルトランスフェラーゼ2の阻害薬として有用なインダゾール誘導体
JPWO2005063737A1 (ja) アミドピラゾール誘導体
JP2021535137A5 (https=)
WO2020203610A1 (ja) 関節リウマチを治療するためのt型カルシウムチャネル阻害剤の使用
JP2009514801A5 (https=)
JP2024525550A5 (https=)
US8507535B2 (en) Methyl-pyrrolidine ether derivatives
RU2019131584A (ru) Комбинация производных изоиндолинона и sgi-110
US20220226299A1 (en) Use of t-type calcium channel blocker for treating pruritus